共 7 条
[1]
Ellenberg S.S., Eisenberger M.A., An efficient design for Phase III studies of combination chemotherapies, Cancer Treatment Reports, 69, pp. 1147-1154, (1985)
[2]
Wieand S., Therneau T., A two‐stage design for randomized trials with binary outcomes, Controlled Clinical Trials, 8, pp. 20-28, (1987)
[3]
Bristol D.R., A one‐sided interim analysis with binary outcomes, Controlled Clinical Trials, 9, pp. 206-211, (1988)
[4]
Thall P.F., Simon R., Ellenberg S.S., Shrager R., Optimal two‐stage designs for clinical trials with binary outcomes, Statistics in Medicine, 7, pp. 571-579, (1988)
[5]
Fleming T.R., One‐sample multiple testing procedure for Phase II clinical trials, Biometrics, 38, pp. 143-151, (1982)
[6]
Schaid D.J., Ingle J.N., Wieand S., Ahmann D.L., A design for Phase II testing of anticancer agents within a Phase III clinical trial, Controlled Clinical Trials, 9, pp. 107-118, (1988)
[7]
Ruckdeschel J.C., Finkelstein D.M., Ettinger D.S., Creech R.H., Mason B.A., Joss R.A., Vogl S., A randomized trial of the four most active regimens for metastatic non‐small‐cell lung cancer, Journal of Clinical Oncology, 4, pp. 14-22, (1986)